Float Short %

3.55

Margin Of Safety %

-26

Put/Call OI Ratio

0.47

EPS Next Q Diff

0.5

EPS Last/This Y

2.22

EPS This/Next Y

0.75

Price

103.44

Target Price

104

Analyst Recom

2.88

Performance Q

48.44

Upside

-137.2%

Beta

1.42

Ticker: EXAS

18 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-01-23	EXAS	102.37	0.41	0.67	39786
2026-01-26	EXAS	102.5	0.41	0.71	40167
2026-01-27	EXAS	102.35	0.41	9.38	40434
2026-01-28	EXAS	102.26	0.43	1.79	40757
2026-01-29	EXAS	102.3	0.43	1.58	40873
2026-01-30	EXAS	102.35	0.43	9.39	41180
2026-02-02	EXAS	102.48	0.45	11.06	41910
2026-02-03	EXAS	102.5	0.47	0.16	42470
2026-02-05	EXAS	102.67	0.47	1.70	42591
2026-02-09	EXAS	103.32	0.47	0.05	42775
2026-02-10	EXAS	103.51	0.46	0.37	43097
2026-02-11	EXAS	103.44	0.46	0.06	43141
2026-02-12	EXAS	103.21	0.46	0.16	43171
2026-02-13	EXAS	103.25	0.46	6.72	43207
2026-02-17	EXAS	103.31	0.46	0.41	43210
2026-02-18	EXAS	103.28	0.46	0.01	43293
2026-02-19	EXAS	103.29	0.45	0.43	43997
2026-02-20	EXAS	103.45	0.47	0.17	44165
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

18 items 1 of 1

20 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-01-23	EXAS	102.37	225.8	1179.4	0.34
2026-01-26	EXAS	102.49	225.8	1180.3	0.34
2026-01-27	EXAS	102.35	225.8	1179.5	0.34
2026-01-28	EXAS	102.28	225.8	1179.7	0.34
2026-01-29	EXAS	102.30	225.8	1179.9	0.34
2026-01-30	EXAS	102.36	225.8	1179.9	0.34
2026-02-02	EXAS	102.51	225.8	1180.1	0.34
2026-02-03	EXAS	102.51	225.8	1179.9	0.34
2026-02-04	EXAS	102.28	225.8	1179.3	0.34
2026-02-05	EXAS	102.66	225.8	1180.6	0.34
2026-02-06	EXAS	103.18	225.8	1180.8	0.34
2026-02-09	EXAS	103.32	225.8	1180.1	0.34
2026-02-10	EXAS	103.34	225.8	1179.8	0.34
2026-02-11	EXAS	103.44	225.8	1180.0	0.34
2026-02-12	EXAS	103.21	225.8	1179.4	0.34
2026-02-13	EXAS	103.25	225.8	1179.9	0.34
2026-02-17	EXAS	103.31	128.8	398.8	1.12
2026-02-18	EXAS	103.33	128.8	398.3	1.12
2026-02-19	EXAS	103.29	100.9	-	1.12
2026-02-20	EXAS	103.44	100.9	-	1.12
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

20 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-01-23	EXAS	-0.73	-3.64	4.56
2026-01-26	EXAS	-0.73	-4.81	4.56
2026-01-27	EXAS	-0.73	-4.81	4.56
2026-01-28	EXAS	-0.73	-4.81	4.03
2026-01-29	EXAS	-0.73	-4.81	4.03
2026-01-30	EXAS	-0.73	-4.81	4.03
2026-02-02	EXAS	-0.73	-5.52	4.03
2026-02-03	EXAS	-0.73	-5.52	4.03
2026-02-04	EXAS	-0.73	-5.52	4.03
2026-02-05	EXAS	-0.73	-5.52	4.03
2026-02-06	EXAS	-0.73	-5.52	4.03
2026-02-09	EXAS	-0.73	-4.73	4.03
2026-02-10	EXAS	-0.73	-4.73	4.03
2026-02-11	EXAS	-0.73	-4.73	3.55
2026-02-12	EXAS	-0.74	-4.73	3.55
2026-02-13	EXAS	-0.74	-4.73	3.55
2026-02-17	EXAS	-0.70	-12.07	3.55
2026-02-18	EXAS	-0.70	-12.07	3.55
2026-02-19	EXAS	-0.70	-12.07	3.55
2026-02-20	EXAS	-0.70	-12.07	3.55
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

-0.21

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

0.29

Insider Transactions

-0.7

Institutional Transactions

-12.07

Beta

1.42

Average Sales Estimate Current Quarter

833

Average Sales Estimate Next Quarter

916

Fair Value

76.18

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

29.4

Max Drawdown 5-Year %

-79.5

Target Price

104

P/E

Forward P/E

82.3

PEG

P/S

6.08

P/B

8.22

P/Free Cash Flow

55.34

EPS

-1.1

Average EPS Est. Cur. Y

1.12

EPS Next Y. (Est.)

1.87

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-6.4

Relative Volume

0.55

Return on Equity vs Sector %

-37.7

Return on Equity vs Industry %

-19.6

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Exact Sciences Corporation

Sector: Healthcare

Industry: Diagnostics & Research

Employees: 7100

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer; Cologuard Plus Tests; Cancerguard Test; and Genetic Testing. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; Oncodetect Test;OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Riskguard Test, a hereditary cancer test to understand their inherited risk of cancer. Its pipeline focus on advancing screening and diagnostic products, including risk assessment, screening and prevention, early disease diagnosis, adjuvant and/or neoadjuvant disease treatment, metastatic disease treatment selection, and recurrence monitoring. The company has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University, as well as Freenome Holdings, Inc. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

stock quote shares EXAS – Exact Sciences Corporation Stock Price stock today

news today EXAS – Exact Sciences Corporation stock forecast ,stock prediction 2023 2024 2025

marketwatch EXAS – Exact Sciences Corporation yahoo finance google finance

stock history EXAS – Exact Sciences Corporation invest stock market

stock prices EXAS premarket after hours

ticker EXAS fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: EXAS

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y